Clinical consequences of polymerase chain reaction‐based diagnosis of intestinal parasitic infections

The implementation of polymerase chain reaction (PCR)‐based diagnostics of intestinal protozoa has led to higher sensitivity and (subtype) specificity, more convenient sampling, and the possibility for high‐throughput screening. PCR for routine detection of human intestinal protozoa in fecal samples is used by an increasing number of clinical laboratories. This paper discusses the recent developments in the diagnosis of intestinal protozoa, with an emphasis on PCR‐based diagnostics. Although many reviews have described the technical aspects of PCR‐based diagnostics, this review focuses on the clinical consequences that result from the shift from microscopic toward PCR‐based diagnostics. Despite its undisputed superiority, the use of PCR comes with challenges that clinicians should be aware of.